Name: adapting 3' rapid amplification of cdna ends to map transcripts in cancer
Uploaded: 2018-03-28T15:00:00
Description: Watch this Scientific Journal Video about Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer at JoVE.com

Vi vil gerne anerkende Bettine Gibbs for hendes teknisk hjælp.

Bære en laboratoriekittel, handsker og sikkerhedsbriller til enhver tid mens de udfører alle procedurer i denne protokol. Sikre, at containere/rør indeholdende phenol og guanidin isothiocyanat reagens kun åbnes i et certificeret hood og bortskaffe phenol affald i en udpegede container. Bruge DNAse/RNAse-fri sterile rør, tips og reagenser.
1. cellekultur
<ol><li>Vokse linjen HeLa celler og to suspension mantle celle lymfom cellelinjer, Granta-519 og Jeko-1, i DMEM som indeholder 10% FBS ...

<ol>
	<li>Mandel, C., Bai, Y., Tong, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protein+factors+in+pre-mRNA+3'-end+processing.">Protein factors in pre-mRNA 3'-end processing.</a> Cell Mol Life Sci. 65 (7-8), 1099-1122 (2008).</li><li>Danckwardt, S., Hentze, M., Kulozik, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=3'+end+mRNA+processing:+Molecular+mechanisms+and+implications+for+health+and+disease.">3' end mRNA processing: Molecular mechanisms and implications for health and disease.</a> EMBO J. 27 (3), 482-498 (2008).</li><li>Derti, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+quantitative+atlas+of+polyadenylation+in+five+mammals.">A quantitative atlas of polyadenylation in five mammals.</a> Genome Res. 22 (6), 1173-1183 (2012).</li><li>Sambrook, J., Russell, D. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapid+amplification+of+3&#8242;+cDNA+ends+(3&#8242;-RACE).">Rapid amplification of 3&#8242; cDNA ends (3&#8242;-RACE).</a> Cold Spring Harb Protoc. 2006 (1), (2006).</li><li>Masamha, C. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CFIm25+regulates+glutaminase+alternative+terminal+exon+definition+to+modulate+miR-23+function.">CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function.</a> RNA. 22 (6), 830-838 (2016).</li><li>Rodu, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+Biology+in+Medicine:+The+polymerase+chain+reaction:+the+revolution+within.">Molecular Biology in Medicine: The polymerase chain reaction: the revolution within.</a> Am J Med Sci. 299 (3), 210-216 (1990).</li><li>Bertioli, D., White, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapid+amplification+of+cDNA+ends.">Rapid amplification of cDNA ends.</a> PCR Cloning Protocols: Methods in Molecular Biology. 67, 233-238 (1997).</li><li>Freeman, L. A., Freeman, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cloning+full-length+transcripts+and+transcript+variants+using+5'+and+3'+RACE.">Cloning full-length transcripts and transcript variants using 5' and 3' RACE.</a> Lipoproteins and Cardiovascular Disease: Methods in Molecular Biology (Methods and Protocols). 1027, 3-17 (2013).</li><li>Masamha, C. P., Albrecht, T. R., Wagner, E. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Discovery+and+characterization+of+a+novel+CCND1/MRCK+gene+fusion+in+mantle+cell+lymphoma.">Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.</a> J Hematol Oncol. 9 (1), 1-5 (2016).</li><li>Parker, B. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+tumorigenic+FGFR3-TACC3+gene+fusion+escapes+miR-99a+regulation+in+glioblastoma.">The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.</a> J Clin Investig. 123 (2), 855-865 (2013).</li><li>Prakash, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Expression+of+conjoined+genes:+Another+mechanism+for+gene+regulation+in+eukaryotes.">Expression of conjoined genes: Another mechanism for gene regulation in eukaryotes.</a> PLOS ONE. 5 (10), e13284 (2010).</li><li>Mertens, F., Johansson, B., Fioretos, T., Mitelman, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+emerging+complexity+of+gene+fusions+in+cancer.">The emerging complexity of gene fusions in cancer.</a> Nat Rev Cancer. 15 (6), 371-381 (2015).</li><li>Mayr, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Evolution+and+biological+roles+of+alternative+3'UTRs.">Evolution and biological roles of alternative 3'UTRs.</a> Trends Cell Biol. 26 (3), 227-237 (2016).</li><li>International Committee For Standardization In, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protocol+for+evaluation+of+automated+blood+cell+counters.">Protocol for evaluation of automated blood cell counters.</a> Clin Lab Haematol. 6 (1), 69-84 (1984).</li><li>Desjardins, P., Conklin, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=NanoDrop+microvolume+quantitation+of+nucleic+acids.">NanoDrop microvolume quantitation of nucleic acids.</a> J Vis Exp. (45), e2565 (2010).</li><li>Lorenz, T. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Polymerase+chain+reaction:+Basic+protocol+plus+troubleshooting+and+optimization+strategies.">Polymerase chain reaction: Basic protocol plus troubleshooting and optimization strategies.</a> J Vis Exp. (63), e3998 (2012).</li><li>Lee, P. Y., Costumbrado, J., Hsu, C. -. Y., Kim, Y. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Agarose+gel+electrophoresis+for+the+separation+of+DNA+fragments.">Agarose gel electrophoresis for the separation of DNA fragments.</a> J Vis Exp. (62), e3923 (2012).</li><li>Curtis, P. C., Thomas, J. L., Phillips, N. R., Roby, R. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optimization+of+primer+specific+filter+metrics+for+the+assessment+of+mitochondrial+DNA+sequence+data.">Optimization of primer specific filter metrics for the assessment of mitochondrial DNA sequence data.</a> Mitochondrial DNA. 21 (6), 191-197 (2010).</li><li>Letowski, J., Brousseau, R., Masson, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Designing+better+probes:+Effect+of+probe+size,+mismatch+position+and+number+on+hybridization+in+DNA+oligonucleotide+microarrays.">Designing better probes: Effect of probe size, mismatch position and number on hybridization in DNA oligonucleotide microarrays.</a> J Microbiol Methods. 57 (2), 269-278 (2004).</li><li>Lefever, S., Pattyn, F., Hellemans, J., Vandesompele, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Single-nucleotide+polymorphisms+and+other+mismatches+reduce+performance+of+quantitative+PCR+assays.">Single-nucleotide polymorphisms and other mismatches reduce performance of quantitative PCR assays.</a> Clin Chem. 59 (10), 1470-1480 (2013).</li><li>Singh, V. K., Govindarajan, R., Naik, S., Kumar, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+effect+of+hairpin+structure+on+PCR+amplification+efficiency.">The effect of hairpin structure on PCR amplification efficiency.</a> Mol Biol Today. 1, 67-69 (2000).</li><li>Kalle, E., Kubista, M., Rensing, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Multi-template+polymerase+chain+reaction.">Multi-template polymerase chain reaction.</a> Biomol Detect Quant. 2, 11-29 (2014).</li><li>Stransky, N., Cerami, E., Schalm, S., Kim, J. L., Lengauer, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+landscape+of+kinase+fusions+in+cancer.">The landscape of kinase fusions in cancer.</a> Nat Commun. 5, 4846 (2014).</li></ol>

På trods af fremkomsten af massive parallelle sekventering teknologier, på grundlag af genet af genet, 3' RACE er stadig den nemmeste og mest økonomiske metode til at identificere de PAS og nukleotider støder op til poly(A) hale. Tilpasning beskrives her udvides ved hjælp af 3' RACE til både forstærke og knytte sekvenser, der omfatter en del af ORF, stop-codon og den hele 3' UTR af ANKHD1 mRNA udskrift. En stor fordel ved 3' RACE er, at med et par mindre tilpasninger, produkter fra 3' RACE kan klones til ...

Dannelsen af 3'-enden er et kritisk skridt i mRNA modning, der omfatter kløvningen af pre-mRNA nedstrøms for et PAS, efterfulgt af tilsætning af ~ 250 untemplated adenines, som udgør poly(A) hale1,2. Poly(A) bindende protein (PABP) bindes til poly(A) hale, og dette beskytter mRNA udskrift fra nedbrydning, og letter oversættelse1.
Aktuelle skøn viser, at 70% af menneskelige gener har flere PASs, og således gennemgår alternative polyadenylation, hvilket resulterer i flere 3' ender3. Det er således vigtigt at identificere hvor poly(A) hale tillægger resten af 3' UTR, samt identificere de PAS, anvendes af enhver given udskrift. Fremkomsten af næste generation sequencing har resulteret i den samtidige identifikation af 3' UTRs og PASs af tusindvis af gener. Denne stigning i sekventering kapacitet har kræves udvikling af bioinformatic algoritmer til analyse af data vedrørende alternative polyadenylation i 3' enden. For de novo påvisning eller validering af PAS og dermed tilknytning til 3' enden af enkelte gener fra store skala sequencing data, forbliver 3' RACE metode valg4,5. De sekvenser, der er inkluderet i cDNA produkter af 3' RACE normalt omfatter kun en del af 3' UTR, der indeholder poly(A) hale, webstedet kavalergang, PAS og sekvenser opstrøms af PAS. I modsætning til PCR, som kræver udformning og anvendelse af genet specifikke frem og bak primere, kræver 3' RACE kun to gen specifikke indlejrede fremad primere. Derfor, PCR kræver en mere detaljeret viden om nucleotidsekvensen af en stor region af genet bliver forstærket4,6. Siden 3' RACE bruger omvendt det samme primer at mål poly(A) hale for alle polyadenylated RNA udskrifter, kun de forreste primere skal gen specifikke, således kun kræver kendskab til en betydeligt mindre region i mRNA. Dette giver mulighed for forstærkning af regioner, hvis sekvenser ikke er fuldt karakteriseret4,7. Dette har tilladt 3' RACE skal bruges ikke kun til at bestemme 3' enden af et gen, men at også bestemme og karakterisere store områder opstrøms i de PAS, der udgør en betydelig del af 3' UTR. Ved at kombinere 5' RACE med den modificerede 3' RACE, der omfatter større dele af 3' UTR og flanken regioner, er det muligt at fuldt sekvens eller klone en hele mRNA udskrift fra 5'-enden til sine 3' enden8.
Et eksempel på denne anvendelse af modificerede 3' RACE er den seneste identifikation af en roman CCND1-MRCK fusion gen udskrift fra Mantle celle lymfom cellelinjer og kræftpatienter. 3' UTR bestod af sekvenser fra både CCND1 og MRCK gener og var genstridige miRNA forordning9. De to indlejrede CCND1 specifikke fremad primere var supplement til området umiddelbart tilstødende og neden for CCND1 stop-codon. Selv om hele transkriptom sekventering sammen med specifikke bioinformatic værktøjer kan anvendes til at påvise gen fusioner inden for 3' UTR10, mange laboratorier kan manglende finansielle midler eller bioinformatic ekspertise til at gøre brug af denne teknologi. Derfor, 3' RACE er et alternativ til de novo identifikation og validering af nye fusion gener der involverer 3' UTR. I betragtning af den drastiske stigning i antallet af rapporterede fusion gener samt læse gennem afskrifter, er 3' RACE blevet et stærkt værktøj i kendetegner gen sekvenser11,12. Derudover har nylige undersøgelser vist, at forskellige sekvenser i 3' UTR såvel som længden af 3' UTR kan påvirke mRNA udskrift stabilitet, lokalisering, translatability og funktion13. Delvis på grund af en øget interesse i kortlægning af transkriptom, har der været en stigning i antallet af forskellige DNA polymeraser der udvikles til brug i laboratoriet. Det er vigtigt at fastslå, hvad slags ændringer kan være foretaget 3' RACE protokol i for at udnytte det tilgængelige repertoire af DNA polymeraser.
Dette arbejde rapporter tilpasning 3' RACE at kortlægge den hele 3' UTR, PAS, og 3' enden kavalergang site af ANKHD1 udskrift ved hjælp af indlejret primere i afsnittet ANKHD1 i afskriften og to forskellige DNA polymeraser.

<table>
	<tbody>
		<tr>
			<td>HeLa cells</td>
			<td>ATCC</td>
			<td>CCL-2</td>
			<td>Cervical cancer cell line.</td>
		</tr>
		<tr>
			<td>Jeko-1 cells</td>
			<td>ATCC</td>
			<td>CRL-3006</td>
			<td>Mantle cell lymphoma cell line.</td>
		</tr>
		<tr>
			<td>Granta-519 cells</td>
			<td>DSMZ</td>
			<td>ACC-342</td>
			<td>Mantle cell lymphoma cell line.</td>
		</tr>
		<tr>
			<td>Fetal Bovine Serum</td>
			<td>Sigma Aldrich</td>
			<td>F6178</td>
			<td>Fetal bovine serum for cell culture.</td>
		</tr>
		<tr>
			<td>Penicillin/Streptomycin</td>
			<td>ThermoFisherScientific</td>
			<td>15140122</td>
			<td>Antibiotic and antimycotic.</td>
		</tr>
		<tr>
			<td>GlycoBlue</td>
			<td>Ambion</td>
			<td>AM9545</td>
			<td>Coprecipitant.</td>
		</tr>
		<tr>
			<td>DMEM</td>
			<td>ThermoFisherScientific</td>
			<td>10569044</td>
			<td>Gibco brand cell culture media with GlutaMAX.</td>
		</tr>
		<tr>
			<td>Nuclease Free-Water</td>
			<td>ThermoFisherScientific</td>
			<td>AM9938</td>
			<td>Ambion DNase and RNAse free water(non DEPC treated).</td>
		</tr>
		<tr>
			<td>Dulbecco&#8217;s Phosphate-Buffered Solution</td>
			<td>Corning</td>
			<td>21-030</td>
			<td>1X PBS.</td>
		</tr>
		<tr>
			<td>Chloroform</td>
			<td>Sigma&#160; Aldrich</td>
			<td>C7559-5VL</td>
			<td></td>
		</tr>
		<tr>
			<td>2-propanol</td>
			<td>Sigma Aldrich</td>
			<td>I9516</td>
			<td></td>
		</tr>
		<tr>
			<td>Reagent Alcohol</td>
			<td>Sigma Aldrich</td>
			<td>793175</td>
			<td>Ethanol</td>
		</tr>
		<tr>
			<td>Ethidium Bromide solution</td>
			<td>Sigma Aldrich</td>
			<td>E1510</td>
			<td></td>
		</tr>
		<tr>
			<td>TRIzol Reagent</td>
			<td>ThermoFisherScientific</td>
			<td>15596026</td>
			<td>Monophasic phenol and guanidine isothiocyanate reagent.</td>
		</tr>
		<tr>
			<td>2X Extender PCR-to-Gel Master Mix</td>
			<td>Amresco</td>
			<td>N867</td>
			<td>2X PCR-to-Gel Master Mix&#160; containing loading dye used in routine quick PCR assays and primer search.</td>
		</tr>
		<tr>
			<td>10mM dNTP</td>
			<td>Amresco</td>
			<td>N557</td>
			<td></td>
		</tr>
		<tr>
			<td>RQ1 RNase-Free DNase</td>
			<td>Promega</td>
			<td>M6101</td>
			<td>Dnase treatment kit.</td>
		</tr>
		<tr>
			<td>Gel Loading Dye Orange (6X)</td>
			<td>New England BioLabs</td>
			<td>B7022S</td>
			<td></td>
		</tr>
		<tr>
			<td>2X Phusion High-Fidelity PCR Master Mix with HF buffer</td>
			<td>ThermoFisherScientific</td>
			<td>F531S</td>
			<td>2X PCR MasterMix containing a chimeric DNA polymerase consisting of a DNA binding domain fused to a Pyrococcus-like proofreading polymerase and other reagents.</td>
		</tr>
		<tr>
			<td>PfuUltra II Fusion HS DNA polymerase</td>
			<td>Agilent Technologies</td>
			<td>600670</td>
			<td>Modified DNA Polymerase from Pyrococcus furiosus (Pfu).</td>
		</tr>
		<tr>
			<td>RevertAid RT Reverse Transcription Kit</td>
			<td>Thermo Fischer</td>
			<td>K1691</td>
			<td>Used for&#160; reverse transcription of mRNA into&#160; cDNA synthesis. Kit includes&#160; Ribolock RNAse inhibitor, RevertAid M-MuLV reverse transcriptase and other reagents listed in manuscript.</td>
		</tr>
		<tr>
			<td>Pefect size 1Kb ladder</td>
			<td>5 Prime</td>
			<td>2500360</td>
			<td>Molecular weight DNA ladder.</td>
		</tr>
		<tr>
			<td>Alpha Innotech FluorChem Q MultiImage III</td>
			<td>Alpha Innotech</td>
			<td></td>
			<td>Used to visualise ethidium bromide stained agarose gel.</td>
		</tr>
		<tr>
			<td>Low Molecular Weight Ladder</td>
			<td>New England BioLabs</td>
			<td>N3233L</td>
			<td>Molecular weight DNA ladder.</td>
		</tr>
		<tr>
			<td>Vortex Mixer</td>
			<td>MidSci</td>
			<td>VM-3200</td>
			<td></td>
		</tr>
		<tr>
			<td>Mini Centrifuge</td>
			<td>MidSci</td>
			<td>C1008-R</td>
			<td></td>
		</tr>
		<tr>
			<td>Dry Bath</td>
			<td>MidSci</td>
			<td>DB-D1</td>
			<td></td>
		</tr>
		<tr>
			<td>NanoDrop 2000C</td>
			<td>ThermoFisherScientific</td>
			<td>ND-2000C</td>
			<td>Spectrophotometer.</td>
		</tr>
		<tr>
			<td>Wide Mini-Sub&#160;Cell GT Horizontal Electrophoresis System</td>
			<td>BioRad</td>
			<td>1704469</td>
			<td>Electrophoresis equipment-apparatus to set up gel</td>
		</tr>
		<tr>
			<td>PowerPac Basic Power Supply</td>
			<td>BioRad</td>
			<td>1645050</td>
			<td>Power supply for gel electrophoresis.</td>
		</tr>
		<tr>
			<td>Agarose</td>
			<td>Dot Scientific</td>
			<td>AGLE-500</td>
			<td></td>
		</tr>
		<tr>
			<td>Mastercycler Gradient</td>
			<td>Eppendorf</td>
			<td>950000015</td>
			<td>PCR thermocycler.</td>
		</tr>
		<tr>
			<td>Centrifuge</td>
			<td>Eppendorf</td>
			<td>5810 R</td>
			<td></td>
		</tr>
		<tr>
			<td>Centrifuge</td>
			<td>Eppendorf</td>
			<td>5430R</td>
			<td></td>
		</tr>
		<tr>
			<td>Wizard SV Gel and PCR Fragment DNA Clean-Up System</td>
			<td>Promega</td>
			<td>A9281</td>
			<td></td>
		</tr>
		<tr>
			<td>Zero Blunt TOPO PCR Cloning Kit, with One Shot&#160; TOP10 Chemically Competent E. coli cells</td>
			<td>ThermoFisherScientific</td>
			<td>K280020</td>
			<td></td>
		</tr>
		<tr>
			<td>MyPCR Preparation Station Mystaire</td>
			<td>MidSci</td>
			<td>MY-PCR24</td>
			<td>Hood dedicated to PCR work.</td>
		</tr>
		<tr>
			<td>Hamilton SafeAire II fume hood</td>
			<td>ThermoFisherScientific</td>
			<td></td>
			<td>Fume hood.</td>
		</tr>
		<tr>
			<td>Beckman Coulter Z1&#160;Particle&#160;Counter</td>
			<td>Beckman Coulter</td>
			<td>6605698</td>
			<td>Particle counter. For counting cells before plating&#160; for RNA extraction.</td>
		</tr>
		<tr>
			<td>Applied Biosystems Sequence Scanner Software v2.0</td>
			<td>Applied Biosystems (through ThermoFisherScientific)</td>
			<td></td>
			<td>Software to analyze Sanger sequencing data.</td>
		</tr>
	</tbody>
</table>

adapting 3' rapid amplification of cdna ends to map transcripts in cancer

Modning af eukaryote mRNAs indebærer 3' enden dannelse, som omfatter tilføjelse af en poly(A) hale. For at kortlægge 3' enden af et gen, er den traditionelle metode til valg 3' hurtige forstærkning af cDNA ender (3' RACE). Protokoller for 3' RACE kræver omhyggelige design og valg af indlejrede primere i den 3' utranslaterede region (3' UTR) target-gen af interesse. Dog med et par ændringer kan til protokollen bruges til at omfatte hele 3' UTR og sekvenser i åben læsning rammen (ORF), giver et mere omfattende billede af forholdet mellem ORF og 3' UTR. Dette er ud over identifikation af polyadenylation signalet (PAS), og på spaltning og polyadenylation webstedet leveres af konventionelle 3' RACE. Udvidet 3' RACE kan opdage usædvanlige 3' UTRs, herunder gen fusioner inden for 3' UTR, og sekvensen oplysninger kan bruges til at forudsige potentielle miRNA bindingssteder samt AU rige destabiliserende elementer, der kan påvirke stabiliteten i afskriften.

Indlejrede fremad Primer søgning:
Agarosegel fra Figur 1 viser to forskellige PCR gel produkter (spor 1 og 2) hvilken brug de samme videresende primer men forskellige omvendt primere. Lane 3 har en særskilt PCR produkt og har en særskilt frem og bak primer. De ideelle primere til brug for PCR baseret reaktion er dem, der giver en særskilt PCR produkt (Lane 3). Den fremad primer anv...

Watch this Scientific Journal Video about Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer at JoVE.com

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer

Tilpasse 3' slutter hurtige forstærkning af CDNA for at kortlægge udskrifter i kræft

De to forskellige 3' hurtige forstærkning af cDNA ender (3' RACE) protokoller beskrevet her gøre brug af to forskellige DNA polymeraser til at knytte sekvenser, der omfatter et segment af åben behandling ramme (ORF), stop-codon og den hele 3' UTR af et udskrift ved hjælp af RNA fremstillet af forskellige kræft cellelinjer.

Maturation of eukaryotic mRNAs involves 3&#39; end formation, which involves the addition of a poly(A) tail. In order to map the 3&#39; end of a gene, the ...

The overall goal of this procedure is to determine the sequences of mRNA transcripts from the three-prime end to regions within the protein coding region by using transcript-specific nested primers in two subsequent PCRs and sequencing the purified PCR products. This method can help answer key questions in the genetic field, such as determining the polyadenylation signal, the stop codon, and the sequence of the three-prime untranslated region of the transcript. The main advantage of this technique is that it can be applied to any transcript if the sequence of the small region of the open reading frame is The implication of this technique extend toward cancer diagnosis, because it can detect tumor specific fusion genes and splice variants.We first had the idea for this method when we identified novel transcripts with previously uncharacterized, three-primed untranslated regions. To begin the protocol, thaw the phenol and guanidine isothiocyanate cell mixture on ice. Once thawed, add 100 microliters of chloroform to the microcentrifuge tube in a PCR hood.Vortex the sample for 10 to 15 seconds until the mixture is pink and opaque. Next, incubate the sample on ice for 15 minutes. After incubation, centrifuge the sample for 15 minutes at 20, 800 g and four degrees Celsius.Carefully remove the upper colorless aqueous phase and transfer it to a new 1.5 milliliter microcentrifuge tube. Then, move on to precipitation and add an equal volume of isopropanol to the sample. Add one microliter of co-precipitant to the sample to act as a carrier for the RNA and to help visualize the RNA in subsequent steps.Incubate the samples at 80 degrees Celsius for at least four hours. After incubation, transfer the sample to a cooled centrifuge and spin for 35 minutes at 20, 800 g and four degrees Celsius. After the spin, the RNA will appear as a blue spec on the bottom of the tube.Carefully remove the isopropanol from the sample. Add 500 microliters of 80%ethanol and resuspend the pellet by briefly vortexing for three seconds. Centrifuge the sample again.Remove all the ethanol from the sample and let the sample air dry for about 10 minutes. Once the sample is dry, resuspend it in 35 microliters of RNase-free water. Then, place the sample on a heat block.Set at 65 degrees Celsius for five minutes to ensure that the RNA is fully in solution. After heating, immediately place the tube on ice. For a final reaction volume of 50 microliters, add four micrograms of total RNA with added water to a total volume of 22 microliters to a new tube.Add two microliters of the Oligo dT 25 primer from the 10 micromolar primer solution. From the reverse transcription kit, add two microliters of the RNase inhibitor, eight microliters of the 5x reaction buffer, four microliters of 10 millimolar dNTPs, and two microliters of the reverse transcriptase. Set up a reaction without reverse transcriptase to act as a negative control.Incubate the tube at 42 degrees Celsius for one hour. After incubation, transfer the tube directly to ice before transporting it to the heating block. Then, heat the tube at 75 degrees Celsius for five minutes.After heating it 75 degrees Celsius, place the tube on ice. Transfer two microliters of the cDNA to a fresh 0.5 milliliter PCR tube. Add one microliter of the forward primer and one microliter of the reverse primer from a 10 millimolar primer solution.Make up to 12.5 microliters by adding 8.5 microliters of nuclease-free water and add 12.5 microliters of the 2x PCR to gel master mix. Then, enter the PCR thermal cycling conditions listed on the screen and run the PCR. After the PCR, prepare a 1%agarose gel stained with ethidium bromide.Dissolve one gram of agarose in 100 milliliters of triacetate or TAE buffer in a 250 milliliter flask. Boil the contents in a microwave. Allow the gel to cool for one minute, and add 7.5 microliters of ethidium bromide solution in a fume hood.Mix well by swirling the flask. Pour the contents into a horizontal gel apparatus and allow the gel to solidify at room temperature in the fume hood for at least 30 minutes. Cover the gel with 1x TAE buffer and load 10 microliters of the PCR product onto the agarose gel together with three to five microliters of the DNA molecular weight ladder.Run the gel at 175 volts for 10 minutes. For the first PCR, transfer one microliter of cDNA to a PCR tube and add five microliters of 10x Pfu reaction buffer. Add one microliter of the first nested forward primer, one microliter of the T7 Oligo dT 25 primer, and one microliter of dNTPs from a 10 millimolar solution.Make up to 49 microliters of total volume by adding 40 microliters of water. Add one microliter of Pfu DNA polymerase and mix well. Then, run the PCR.Next, prepare the second PCR. Transfer two microliters of the products from the first PCR to a new PCR tube and mix it with five microliters of 10x Pfu ultra two reaction buffer. Add one microliter of the second nested PCR primer, one microliter of the T7 primer and one microliter of dNTPs.Make up to 49 microliters total reaction volume by adding 39 microliters of water and add one microliter of Pfu DNA polymerase. Run the PCR using the same PCR profile as the first PCR set up. Alternatively, instead of using Pfu DNA polymerase, a chimeric DNA polymerase can be used in the two different PCRs.Take five to ten microliters of the second PCR product and run it on an agarose gel. Finally, visualize the result on an imager. This agarose gel shows two distinct PCR products which use the same forward primer but different reverse primers and a distinct PCR product that has a distinct forward and reverse primer.The ideal primers to use for the PCR based reaction are those that give one distinct PCR product. Products from the second PCR reaction with Pfu DNA polymerase and chimeric DNA polymerase produced the same sized PCR products despite having different PCR cycling conditions for the three-prime RACE. The reverse transcriptase negative controls showed no genomic contamination of the RNA used in cDNA synthesis as well as in subsequent downstream reactions.Gel-purified PCR products were sent for sequencing. A representative Sanger sequence from a sequence chromatogram identified the location of the stop codon, putative polyadenylation signal and the site as well as the poly A tail in the three-prime RACE product. While attempting this procedure, it's important to remember to wear protective gear and gloves at all time.In addition, use sterile DNase and RNase for your reagents tubes and other disposables. Don't forget that working with phenol and chloroform can be extremely hazardous. And precautions such as using the reagents in a hood and disposing material in a designated waste container should always be taken while performing this procedure.

Research

JoVE Journal

Genetics

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Fletning absolutte og relative kvantitativ PCR data at kvantificere STAT3 Splice Variant Afskrifter

Human signal transducer and activator of transcription 3 (STAT3) is one of many genes containing a tandem splicing site. Alternative donor splice sites 3 ...

High Resolution Fluorescent In Situ Hybridization in Drosophila Embryos and Tissues Using Tyramide Signal Amplification

High Resolution Fluorescent In Situ Hybridization in Drosophila Embryos and Tissues Using Tyramide Signal Amplification

Høj opløsning fluorescerende In Situ hybridisering i Drosophila fostre og væv ved hjælp af Tyramide Signal forstærkning

In our efforts to determine the patterns of expression and subcellular localization of Drosophila RNAs on a genome-wide basis, and in a variety of ...

CRISPR-Mediated Reorganization of Chromatin Loop Structure

CRISPR-medieret reorganisering af kromatin løkke struktur

Recent studies have clearly shown that long-range, three-dimensional chromatin looping interactions play a significant role in the regulation of gene ...

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers

En murine cellelinje baseret model af kronisk CDK9 hæmning at studere udbredte ikke-genetiske Transkriptional forlængelse defekter (TEabsolut) i kræft

We have previously reported that a subset of cancers is defined by global transcriptional deregulations with widespread deficiencies in mRNA transcription ...

Discrimintion and Mapping of the Primary and Processed Transcripts in Maize Mitochondrion Using a Circular RT-PCR-based Strategy

Diskrimination og kortlægning af primære og forarbejdede transskriptioner i majs mitokondrier ved hjælp af en cirkulær RT-PCR-baseret strategi

In plant mitochondria, some steady-state transcripts have 5&#39; triphosphate derived from transcription initiation (primary transcripts), while the ...

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Undersøgelse af den transkriptionelle rolle af en RUNX1 intronic LYDDÆMPER af crispr/Cas9 ribonucleoprotein i akutte myeloid leukæmiceller

The bulk of the human genome (~98%) is comprised of non-coding sequences. Cis-regulatory elements (CREs) are non-coding DNA sequences that contain binding ...

Detection of Human Immunodeficiency Virus Type 1 (HIV-1) Antisense Protein (ASP) RNA Transcripts in Patients by Strand-Specific RT-PCR

Detection of Human Immunodeficiency Virus Type 1 HIV-1 Antisense Protein ASP RNA Transcripts in Patients by Strand-Specific RT-PCR

Påvisning af humant immundefekt virus type 1 (HIV-1) antisense protein (ASP) RNA-transskriptioner hos patienter med streng specifik RT-PCR

In retroviruses, antisense transcription has been described in both human immunodeficiency virus type 1 (HIV-1) and human T-lymphotropic virus 1 (HTLV-1). ...

Efficient Transcriptionally Controlled Plasmid Expression System for Investigation of the Stability of mRNA Transcripts in Primary Alveolar Epithelial Cells

Effektivt transskriptionelt plasmidekspressionssystem til undersøgelse af stabiliteten af mRNA-udskrifter i primære alveolære epitelceller

Studying posttranscriptional regulation is fundamental to understanding the modulation of a given messenger RNA (mRNA) and its impact on cell homeostasis ...

Screening Sperm for the Rapid Isolation of Germline Edits in Zebrafish

Screening af sædceller for hurtig isolering af kimlinjeredigeringer hos zebrafisk

The advent of targeted CRISPR-Cas nuclease technologies has revolutionized the ability to perform precise genome editing in both established and emerging ...